Cadus Corp – ‘S-8 POS’ on 12/23/97 – EX-23.1

As of:  Tuesday, 12/23/97   ·   Effective:  12/23/97   ·   Accession #:  889812-97-2729   ·   File #:  333-21871

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Post-Effective Amendment to an S-8   —   Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8 POS     Post-Effective Amendment No. 2                         5     21K 
 2: EX-4        Amendment No. 2 to Cadus Pharmaceutical                1      5K 
                          Corporation 1996 Incentive Plan                        
 3: EX-5        Opinion of Morrison Cohen Singer & Weinstein, LLP,     2±     8K 
                          as to the Validity of the Securities                   
                          Being Registered                                       
 4: EX-23.1     Consent of Kpmg Peat Marwick LLP                       1      5K 

EX-23.1   —   Consent of Kpmg Peat Marwick LLP

EX-23.1
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
Independent Auditors' Consent   
-----------------------------   

The Board of Directors                                                          
Cadus Pharmaceutical Corporation:                                               

We consent to the use of our report incorporated herein by reference.           

White Plains, New York                                                          
December 22, 1997                      /s/ KPMG Peat Marwick LLP                

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-8 POS’ Filing		Date		Other Filings
Filed on / Effective on:		12/23/97		None on these Dates
		12/22/97
				List all Filings